Pentoxifylline inhibits platelet-derived growth factor-stimulated cyclin D1 expression in mesangial cells by blocking Akt membrane translocation.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Molecular Pharmacology

• Publication date

  2003-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/mol.64.4.811PMID 14500737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor necrosis factor-alpha stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: down-regulation by cAMP.

  2003cited by this paper
• Selective down-regulation of c-jun gene expression by pentoxifylline and c-jun antisense interrupts platelet-derived growth factor signaling: pentoxifylline inhibits phosphorylation of c-Jun on serine 73.

  2002influential reference
• Ceramide-induced Inhibition of Akt Is Mediated through Protein Kinase Cζ

  2002cited by this paper
• Pentoxifylline attenuated the renal disease progression in rats with remnant kidney.

  2002cited by this paper
• PKB/AKT: functional insights from genetic models

  2001cited by this paper
• Akt Serine Threonine Kinase Regulates Platelet-derived Growth Factor-induced DNA Synthesis in Glomerular Mesangial Cells

  2001influential reference
• Activation of Akt (Protein Kinase B) in Mammary Epithelium Provides a Critical Cell Survival Signal Required for Tumor Progression

  2001cited by this paper
• PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.

  2001influential reference
• Ceramide dissociates 3'-phosphoinositide production from pleckstrin homology domain translocation.

  2001cited by this paper
• cAMP signaling selectively influences Ras effectors pathways

  2001cited by this paper
• Use of pentoxifylline in membranous nephropathy.

  2001cited by this paper
• Cyclic AMP Inhibits Extracellular Signal-regulated Kinase and Phosphatidylinositol 3-Kinase/Akt Pathways by Inhibiting Rap1*

  2001cited by this paper
• Growth-factor-dependent mitogenesis requires two distinct phases of signalling

  2001influential reference
• Structural mechanism for STI-571 inhibition of abelson tyrosine kinase.

  2000cited by this paper
• Requirement of cyclin D1 in mesangial cell mitogenesis.

  2000influential reference
• Interleukin-6 Inhibits Transforming Growth Factor-β-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Akt and Signal Transducers and Activators of Transcription 3 Pathways*

  1999influential reference
• Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.

  1999cited by this paper
• PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1.

  1999cited by this paper
• Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullin.

  1999cited by this paper
• Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers.

  1999cited by this paper
• Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration.

  1999cited by this paper
• Pentoxifylline inhibits PDGF-induced proliferation of and TGF-beta-stimulated collagen synthesis by vascular smooth muscle cells.

  1999cited by this paper
• Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).

  1998influential reference
• Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.

  1998influential reference
• Cyclin D1, p16, and retinoblastoma gene regulate mitogenic signaling of endothelin in rat mesangial cells.

  1998cited by this paper
• Suppression of transforming growth factor-β-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway

  1998cited by this paper
• 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase.

  1997cited by this paper
• Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1.

  1997cited by this paper
• PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF.

  1997influential reference
• Phosphoinositide 3-kinases: a conserved family of signal transducers.

  1997cited by this paper
• The consensus motif for phosphorylation by cyclin D1‐Cdk4 is different from that for phosphorylation by cyclin A/E‐Cdk2.

  1996cited by this paper
• Inhibition by pentoxifylline of extracellular signal‐regulated kinase activation by platelet‐derived growth factor in hepatic stellate cells

  1996influential reference
• Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis.

  1996cited by this paper
• Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway.

  1995cited by this paper
• Vasodilator agents modulate rat glomerular mesangial cell growth and collagen synthesis.

  1995cited by this paper
• Cyclin G: a new mammalian cyclin with homology to fission yeast Cig1.

  1993cited by this paper
• Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor

  1992cited by this paper
• Progression of renal disease.

  1989cited by this paper
• J Am Soc Nephrol 12: 909–918, 2001 Specific Antagonism of PDGF Prevents Renal Scarring in Experimental Glomerulonephritis

  year unknowncited by this paper

• Pentoxifylline Enhances the Effects of Doxorubicin and Bleomycin on Apoptosis, Caspase Activity, and Cell Cycle While Reducing Proliferation and Senescence in Hodgkin’s Disease Cell Line

  2025cites this paper
• Oxidative Mechanism of Peyronie’s Disease and Effectiveness of Pentoxifylline in the Therapeutic Management: A Narrative Review

  2025cites this paper
• Role of Oxidative Stress in Peyronie’s Disease: Biochemical Evidence and Experiences of Treatment with Antioxidants

  2022cites this paper
• Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease

  2022cites this paper
• Pentoxifylline-induced protein expression change in RAW 264.7 cells as determined by immunoprecipitation-based high performance liquid chromatography

  2021cites this paper
• Fabrication of Pentoxifylline-Loaded Hydroxyapatite/Alginate Scaffold for Bone Tissue Engineering

  2020cites this paper
• Pentoxifylline for Renal Protection in Diabetic Kidney Disease. A Model of Old Drugs for New Horizons

  2019cites this paper
• Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update

  2017cites this paper
• Combination Therapeutic Strategies Targeting Growth and Metabolic Pathways in Prostate Cancer

  2016cites this paper
• Effect of Pentoxifylline on Microalbuminuria in Diabetic Patients: A Randomized Controlled Trial

  2015cites this paper
• Pentoxifylline inhibits angiotensin II-induced proliferation in rat vascular smooth muscle cells

  2015cites this paper
• Carboplatin-induced Fanconi-like syndrome in rats: amelioration by pentoxifylline.

  2014cites this paper
• Pentoxifylline and propentofylline prevent proliferation and activation of the mammalian target of rapamycin and mitogen activated protein kinase in cultured spinal astrocytes

  2013cites this paper
• Curbing the focal adhesion kinase and its associated signaling events by pentoxifylline in MDA-MB-231 human breast cancer cells.

  2013cites this paper
• Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β.

  2012cites this paper
• Transforming Growth Factor b-1 Stimulates Pro fi brotic Epithelial Signaling to Activate Pericyte-Myo fi broblast Transition in Obstructive Kidney Fibrosis

  2012cites this paper
• Preclinical evaluation of the antimetastatic efficacy of Pentoxifylline on A375 human melanoma cell line.

  2012cites this paper
• New options and perspectives for proteinuria management after kidney transplantation.

  2012cites this paper
• Bufalin inhibits platelet-derived growth factor-BB-induced mesangial cell proliferation through mediating cell cycle progression.

  2011cites this paper
• Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells

  2011cites this paper
• Crocetin inhibits cell cycle G1/S transition through suppressing cyclin D1 and elevating p27kip1 in vascular smooth muscle cells

  2010cites this paper
• Prolonged Administration Enhances the Renoprotective Effect of Pentoxifylline via Anti-Inflammatory Activity in Streptozotocin-Induced Diabetic Nephropathy

  2010cites this paper
• Pentoxifylline modulates p47phox activation and downregulates neutrophil oxidative burst through PKA-dependent and -independent mechanisms

  2010cites this paper
• Effects of Pentoxifylline on Amikacin-Induced Nephrotoxicity in Rats

  2009cites this paper
• Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes.

  2008cites this paper
• Retractile mesenteritis presenting with malabsorption syndrome. Successful treatment with oral pentoxifylline.

  2008cites this paper
• Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.

  2008cites this paper
• PENGARUH PENTOXIFYLLINE TERHADAP FIBROINDEKS PADA PENDERITA HEPATITIS KRONIS B

  2008cites this paper
• Pentoxifylline attenuation of experimental hepatopulmonary syndrome.

  2007cites this paper
• Endothelin-1 activates MAPKs and modulates cell cycle proteins in OKP cells.

  2007cites this paper
• Caffeine analogs: biomedical impact

  2007cites this paper
• Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis.

  2006cites this paper
• Blocking of Akt/NF-κB Signaling by Pentoxifylline Inhibits Platelet-Derived Growth Factor–Stimulated Proliferation in Brown Norway Rat Airway Smooth Muscle Cells

  2006cites this paper
• YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.

  2005cites this paper
• Therapeutics in Renal Disease: The Road Ahead for Antiproliferative Targets

  2005cites this paper
• The Renoprotective Potential of Pentoxifylline in Chronic Kidney Disease

  2005cites this paper
• Rôle des sphingolipides endogènes dans les modifications de la prolifération des cellules mésangiales rénales en réponse aux produits avancés de glycation (AGE) : implication dans le développement de la néphropathie diabétique

  2005cites this paper
• Vasodilator agents inhibit opossum kidney proximal tubular cell growth.

  2005cites this paper
• Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor.

  2005cites this paper
• Role of cyclins in cAMP inhibition of glomerular mesangial cell proliferation.

  2004cites this paper
• Pentoxifylline: A potential therapy for chronic kidney disease

  2004cites this paper